Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma

Immune checkpoint inhibition has resulted in dramatic improvements in overall and relapse-free survival in patients with metastatic melanoma. The most commonly used immune checkpoint inhibitors are monoclonal antibodies targeting programmed cell death protein 1 and cytotoxic T-lymphocyte-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kümpers, Christiane, Jokic, Mladen, Haase, Ozan, Offermann, Anne, Vogel, Wenzel, Grätz, Victoria, Langan, Ewan A., Perner, Sven, Terheyden, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425878/
https://www.ncbi.nlm.nih.gov/pubmed/30931305
http://dx.doi.org/10.3389/fmed.2019.00027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425878/
https://www.ncbi.nlm.nih.gov/pubmed/30931305
http://dx.doi.org/10.3389/fmed.2019.00027

Ejemplares similares